MEG3 and Parkinson disease: The results showed that the relative expression levels of plasma lncRNA MEG3 are reduced in PD patients compared to those of the healthy population, shows that lncRNA MEG3 is one of the most important potential molecular in the diagnosis of PD or selection of therapeutic potential targets.